Epidemiological features of COVID 19 in Iran

The first confirmed case of COVID?19 in Iran was reported in February 2019. The current study aimed to investigate the epidemiological aspects of COVID?19 disease in Isfahan province and evaluate the chances of infection and death in the population.

In this cross?sectional study, 21,203 confirmed cases of COVID?19, based on the polymerase chain reaction test, referred to outpatient facilities from February 2019 to July 2020 in Isfahan province are studied. Disease incidence, mortality, and case fatality rate, as well as odds ratio (OR) of infection and death, were calculated and analyzed using SPSS version 20.

The highest incidence of the disease was within the age group of 30–39 years 4911 (23.9%) and males 11,561 (54.5%). Mortality in people over 80 years (207 [32.9%]), men (370 cases [58.7%]), diabetics (182 cases [28.9%]), and people with  ardiovascular disease (165 people [26.2%]) was more. In multivariateanalysis, patients with a cancer diagnosis had the highest OR of death (OR = 4.03 confidence interval [CI]: 2.56–6.35) (P < 0.001), followedby those with immune deficiency disease (OR = 2.46 CI: 1.07–5.63) (P = 0.03). As the number of comorbidities increased, the risk of death increased in the total population, so that in patients with more than 4  nderlying diseases, compared to the group without disease, the chance of death increased 6.33 times.

This study showed that people  ith cancer and chronic respiratory disease had a higher chance of COVID?19 infection. People over the age of 60, people with cancer, and immunodeficiency also had a higher chance of COVID?19 mortalityW.